-
Mashup Score: 0Updates on HCV Screening, Access to Treatment, and Prevention - 8 month(s) ago
Thought leaders examine challenges and opportunities in HCV screening and prevention, in highlights from a recent State of the Science SummitTM, presented by HCP Live®
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
An exclusive event from our partners at HCPLive®. Explore strategies for #HCV prevention by expanding access to treatment. Watch the Updates on HCV Screening, Access to Treatment, and Prevention on-demand workshop. #infectiousdiseases https://t.co/68PUZn15Iw https://t.co/x3J2abL3Kk
-
-
Mashup Score: 0Updates on HCV Screening, Access to Treatment, and Prevention - 9 month(s) ago
Thought leaders examine challenges and opportunities in HCV screening and prevention, in highlights from a recent State of the Science SummitTM, presented by HCP Live®
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Explore strategies for #HCV prevention by expanding access to treatment. Watch the Updates on HCV Screening, Access to Treatment, and Prevention on-demand workshop. #infectiousdiseases https://t.co/EQFjUH5iJm https://t.co/mfMzB3B1aS
-
An exclusive event from our partners at HCPLive®. Explore strategies for #HCV prevention by expanding access to treatment. Watch the Updates on HCV Screening, Access to Treatment, and Prevention on-demand workshop. #infectiousdiseases https://t.co/68PUZn1Dy4 https://t.co/IOtPxm1q0Y
-
-
Mashup Score: 0Updates on HCV Screening, Access to Treatment, and Prevention - 9 month(s) ago
Thought leaders examine challenges and opportunities in HCV screening and prevention, in highlights from a recent State of the Science SummitTM, presented by HCP Live®
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Explore strategies for #HCV prevention by expanding access to treatment. Watch the Updates on HCV Screening, Access to Treatment, and Prevention on-demand workshop. #infectiousdiseases https://t.co/EQFjUH4KTO https://t.co/1BnNGnAV9u
-
An exclusive event from our partners at HCPLive®. Explore strategies for #HCV prevention by expanding access to treatment. Watch the Updates on HCV Screening, Access to Treatment, and Prevention on-demand workshop. #infectiousdiseases https://t.co/68PUZn15Iw https://t.co/mzqBp8O59N
-
-
Mashup Score: 0COVID-19 in Oromia Region of Ethiopia: a review of the first 6 months’ surveillance data - 9 month(s) ago
Introduction Despite unrelenting efforts to contain its spread, COVID-19 is still causing unprecedented global crises. Ethiopia reported its first case on 13 March 2020 but has an accelerated case load and geographical distribution recently. In this article, we described the epidemiology of COVID-19 in Oromia Region, the largest and most populous region in Ethiopia, during the early months of the outbreak. Methods We analysed data from the COVID-19 surveillance database of the Oromia Regional Health Bureau. We included all reverse transcription-PCR-confirmed cases reported from the region between 13 March and 13 September 2020. Results COVID-19 was confirmed in 8955 (5.5%) of 164 206 tested individuals. The test positivity rate increased from an average of 1.0% in the first 3 months to 6.3% in August and September. About 70% (6230) of the cases were men; the mean age was 30.0 years (SD=13.3), and 90.5% were <50 years of age. Only 64 (0.7%) of the cases had symptoms at diagnosis. Cough
Source: bmjopen.bmj.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Read one of our top cited papers in #infectiousdiseases: #COVID-19 in Oromia Region of Ethiopia: a review of the first 6 months’ surveillance data https://t.co/YLOrIvAO5a https://t.co/8oG5XYUjRu
-
-
Mashup Score: 0Updates on HCV Screening, Access to Treatment, and Prevention - 9 month(s) ago
Thought leaders examine challenges and opportunities in HCV screening and prevention, in highlights from a recent State of the Science SummitTM, presented by HCP Live®
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Explore strategies for #HCV prevention by expanding access to treatment. Watch the Updates on HCV Screening, Access to Treatment, and Prevention on-demand workshop. #infectiousdiseases https://t.co/EQFjUH4KTO https://t.co/5TJjg6bWiy
-
An exclusive event from our partners at HCPLive®. Explore strategies for #HCV prevention by expanding access to treatment. Watch the Updates on HCV Screening, Access to Treatment, and Prevention on-demand workshop. #infectiousdiseases https://t.co/68PUZn15Iw https://t.co/WykxoUq4Wv
-
-
Mashup Score: 0
Introduction Leprosy, or Hansen’s disease, remains a cause of preventable disability. Early detection, treatment and prevention are key to reducing transmission. Post-exposure prophylaxis with single-dose rifampicin (SDR-PEP) reduces the risk of developing leprosy when administered to screened contacts of patients. This has been adopted in the WHO leprosy guidelines. The PEP4LEP study aims to determine the most effective and feasible method of screening people at risk of developing leprosy and administering chemoprophylaxis to contribute to interrupting transmission. Methods and analysis PEP4LEP is a cluster-randomised implementation trial comparing two interventions of integrated skin screening combined with SDR-PEP distribution to contacts of patients with leprosy in Ethiopia, Mozambique and Tanzania. One intervention is community-based, using skin camps to screen approximately 100 community contacts per leprosy patient, and to administer SDR-PEP when eligible. The other intervention
Source: bmjopen.bmj.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Read one of our top cited papers in #infectiousdiseases: PEP4LEP study protocol: integrated skin screening and SDR-PEP administration for #leprosy prevention https://t.co/rVip17F2bF https://t.co/fgx0IGSlKi
-
-
Mashup Score: 0Downsides of face masks and possible mitigation strategies: a systematic review and meta-analysis - 9 month(s) ago
Objective To identify, appraise and synthesise studies evaluating the downsides of wearing face masks in any setting. We also discuss potential strategies to mitigate these downsides. Design Systematic review and meta-analysis. Data sources PubMed, Embase, CENTRAL and EuropePMC were searched (inception–18 May 2020), and clinical registries were searched via CENTRAL. We also did a forward–backward citation search of the included studies. Inclusion criteria We included randomised controlled trials and observational studies comparing face mask use to any active intervention or to control. Data extraction and analysis Two author pairs independently screened articles for inclusion, extracted data and assessed the quality of included studies. The primary outcomes were compliance, discomforts, harms and adverse events of wearing face masks. Results We screened 5471 articles, including 37 (40 references); 11 were meta-analysed. For mask wear adherence, 47% (95% CI 25% to 68%, p<0.0001), more p
Source: bmjopen.bmj.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Read one of our top cited papers in #infectiousdiseases: Downsides of face masks and possible mitigation strategies: a systematic review and meta-analysis https://t.co/w6Rqy08STc https://t.co/hizYbR8o8g
-
-
Mashup Score: 0Systematic review of prediction models for pulmonary tuberculosis treatment outcomes in adults - 9 month(s) ago
Objective To systematically review and critically evaluate prediction models developed to predict tuberculosis (TB) treatment outcomes among adults with pulmonary TB. Design Systematic review. Data sources PubMed, Embase, Web of Science and Google Scholar were searched for studies published from 1 January 1995 to 9 January 2020. Study selection and data extraction Studies that developed a model to predict pulmonary TB treatment outcomes were included. Study screening, data extraction and quality assessment were conducted independently by two reviewers. Study quality was evaluated using the Prediction model Risk Of Bias Assessment Tool. Data were synthesised with narrative review and in tables and figures. Results 14 739 articles were identified, 536 underwent full-text review and 33 studies presenting 37 prediction models were included. Model outcomes included death (n=16, 43%), treatment failure (n=6, 16%), default (n=6, 16%) or a composite outcome (n=9, 25%). Most models (n=30, 81%)
Source: bmjopen.bmj.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Read one of our top cited papers in #infectiousdiseases: Systematic review of prediction models for #pulmonary #tuberculosis treatment outcomes in adults https://t.co/8kFmR1gvDh https://t.co/RUwLuCK4bs
-
-
Mashup Score: 0Updates on HCV Screening, Access to Treatment, and Prevention - 9 month(s) ago
Thought leaders examine challenges and opportunities in HCV screening and prevention, in highlights from a recent State of the Science SummitTM, presented by HCP Live®
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Explore strategies for #HCV prevention by expanding access to treatment. Watch the Updates on HCV Screening, Access to Treatment, and Prevention on-demand workshop. #infectiousdiseases https://t.co/EQFjUH4KTO https://t.co/IYbNrv2gNM
-
An exclusive event from our partners at HCPLive®. Explore strategies for #HCV prevention by expanding access to treatment. Watch the Updates on HCV Screening, Access to Treatment, and Prevention on-demand workshop. #infectiousdiseases https://t.co/68PUZn15Iw https://t.co/bxWTNFToW3
-
-
Mashup Score: 0Updates on HCV Screening, Access to Treatment, and Prevention - 10 month(s) ago
Thought leaders examine challenges and opportunities in HCV screening and prevention, in highlights from a recent State of the Science SummitTM, presented by HCP Live®
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Explore strategies for #HCV prevention by expanding access to treatment. Watch the Updates on HCV Screening, Access to Treatment, and Prevention on-demand workshop. #infectiousdiseases https://t.co/EQFjUH5iJm https://t.co/uAaenUnE4G
-
An exclusive event from our partners at HCPLive®. Explore strategies for #HCV prevention by expanding access to treatment. Watch the Updates on HCV Screening, Access to Treatment, and Prevention on-demand workshop. #infectiousdiseases https://t.co/68PUZn1Dy4 https://t.co/JG1KtWeCuS
-
Explore strategies for #HCV prevention by expanding access to treatment. Watch the Updates on HCV Screening, Access to Treatment, and Prevention on-demand workshop. #infectiousdiseases https://t.co/EQFjUH4KTO https://t.co/FcTsWEwIJ6